Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07296952 · ClinicalTrials.gov registry record · NA
Using Implementation Science to Adapt a Targeted Transportation Intervention for Patients With Diabetic Retinopathy (PRONTO-EYE)
A NA study of Diabetic Retinopathy (DR), sponsored by University of Illinois at Chicago.
- Recruiting
- Registry status
- NA
- Development phase
- 60
- Enrollment target
- 1
- Study location
NCT07296952: Recruiting NA study of Diabetic Retinopathy (DR), sponsored by University of Illinois at Chicago.
NCT07296952 is a NA study of Diabetic Retinopathy (DR) that is actively recruiting participants, run by University of Illinois at Chicago. The registered enrollment target is 60 participants, below the 498-participant average among 5 other Diabetic Retinopathy (DR) trials with a reported enrollment target (88% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT07296952, a NA study of Diabetic Retinopathy (DR), is actively recruiting participants, sponsored by University of Illinois at Chicago.
- RECRUITING
- Registry status
- NA
- Development phase
- 60 participants
- Enrollment target
- 1
- Study location
Study Summary
This is a a type 3 hybrid effectiveness-implementation pilot study to evaluate the PRONTO-EYE intervention, a rideshare transportation program, in patients with diabetic retinopathy with Medicaid insurance on adherence to ophthalmology visits.
Primary Outcome
Proportion of patients who attend their scheduled ophthalmology visit compared to pre-implementation historical controls.
Conditions Studied
Interventions
- BEHAVIORAL PRONTO-EYE
Study Locations (1)
Illinois
- UI Health - Chicago
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 60 participants |
| Start Date | 2026-02-03 |
| Est. Completion | 2027-06-01 |
| Phase | NA |
What NCT07296952 shows while recruiting
NCT07296952 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 60 participants, a relatively small participant target, below the 498-participant average among 5 other Diabetic Retinopathy (DR) trials with a reported enrollment target (88% lower).
The record links to 1 condition, with Diabetic Retinopathy (DR) appearing as the primary indexed condition, and to 1 intervention - of which PRONTO-EYE is the first listed.
NCT07296952 reports a single indexed study location in Illinois.
Frequently Asked Questions
What is clinical trial NCT07296952 about?
NCT07296952 is a clinical study titled "Using Implementation Science to Adapt a Targeted Transportation Intervention for Patients With Diabetic Retinopathy (PRONTO-EYE)". This is a a type 3 hybrid effectiveness-implementation pilot study to evaluate the PRONTO-EYE intervention, a rideshare transportation program, in patients with diabetic retinopathy with Medicaid insurance on adherence to ophthalmology visits.
What is the current status of trial NCT07296952?
This trial is currently recruiting. It is a NA study. The enrollment target is 60 participants. The study started on 2026-02-03. Estimated completion is 2027-06-01.
What conditions does trial NCT07296952 study?
This clinical trial studies the following conditions: Diabetic Retinopathy (DR).
What interventions are being tested in trial NCT07296952?
The interventions under investigation include: PRONTO-EYE (BEHAVIORAL).
Who is sponsoring clinical trial NCT07296952?
This trial is sponsored by University of Illinois at Chicago, which has 430 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT07296952 being conducted?
This trial has 1 study location across Illinois. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Diabetic Retinopathy (DR)
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Diabetic Retinopathy Screening Point-of-Care Artificial Intelligence
ACTIVE NOT RECRUITING · NA
-
Efficacy and Safety of AEYE Diagnostic Screening (AEYE-DS) Software Device for Detection of Diabetic Retinopathy From Digital Funduscopic Images
COMPLETED · NA
-
Assessment of AI Program 'DRISTi' as a Screening Tool
RECRUITING
-
RGX-314 Gene Therapy Administered in the Suprachoroidal Space for Participants With Diabetic Retinopathy (DR) With and Without Center Involved-Diabetic Macular Edema (CI-DME)
ACTIVE NOT RECRUITING · Phase 2
-
A Real-World Study of Interventional Clinical Outcomes in Patients With Open Angle Glaucoma and Other Chronic Eye Diseases
ACTIVE NOT RECRUITING
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00576069 · 60 participants
Mechanism(s)of Airflow Limitation in Moderate-severe Persistent Asthma
- NCT01297400 · 60 participants · Phase 2
Phase 2 Pilot Study of the Safety and Efficacy of Topical MW-III in Thermal Burns
- NCT01734122 · 60 participants
Stereotactic Radiosurgery for Essential Tremor and Parkinsonian Tremor
- NCT01804634 · 60 participants · Phase 2
Reduced Intensity Haploidentical BMT for High Risk Solid Tumors
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI